Research in space will use Emulate’s Organs-on-Chips technology to evaluate effects of space travel on human brain cells, and may help uncover new insights to understand neurological diseases on Earth
$2 million grant provided by NCATS, a center of the NIH; logistical support provided by CASIS, managers of the International Space Station U.S. National Laboratory
BOSTON, Mass., June 20, 2017 — Emulate, Inc. announced today that it has received a research grant to use the company’s human Brain-Chip system and develop a fully automated research platform, to conduct experiments on the International Space Station. Studies will analyze the Brain-Chip, which consists of neuronal and vascular endothelial cells in a living micro-engineered environment. Experiments will be conducted under healthy and inflamed states to assess how space travel affects neuronal function.
The NIH’s National Center for Advancing Translational Sciences (NCATS) provided the award of $2 million. The Center for the Advancement of Science in Space (CASIS), the organization tasked by NASA to manage and promote research onboard the International Space Station U.S. National Laboratory, will coordinate the implementation of Emulate’s Human Emulation System to conduct research in space.